BiotechTube

IV diuretic

Pre-clinicalCompleted
0 watching 0 views this weekπŸ’€ Quiet
15
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Congestive Heart Failure

Conditions

Congestive Heart Failure

Trial Timeline

Apr 1, 2004 β†’ Oct 1, 2005

NCT ID
NCT00124137

About IV diuretic

IV diuretic is a pre-clinical stage product being developed by Nuwellis for Congestive Heart Failure. The current trial status is completed. This product is registered under clinical trial identifier NCT00124137. Target conditions include Congestive Heart Failure.

Hype Score Breakdown

Clinical
5
Activity
2
Company
2
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT00124137Pre-clinicalCompleted

Competing Products

20 competing products in Congestive Heart Failure

See all competitors
ProductCompanyStageHype Score
Carperitide + PlaceboDaiichi SankyoPhase 2
52
Seloken ZOK/Toprol-XL + Seloken ZOK/Toprol-XL + PlaceboAstraZenecaPhase 3
77
Candesartan + PlaceboAstraZenecaPhase 3
77
AC2592 + placeboAstraZenecaPhase 2
52
Dapagliflozin + PlaceboAstraZenecaApproved
85
Enoximone + Metoprolol succinate + Placebo to match enoximone + Placebo to match metoprolol succinateAstraZenecaPhase 3
77
Candesartan + PlaceboAstraZenecaPhase 3
77
Candesartan + PlaceboAstraZenecaPhase 3
77
RosuvastatinAstraZenecaPhase 3
77
KW-3902IVMerckPhase 2
52
rolofylline + Comparator: Placebo (unspecified)MerckPhase 3
77
KW-3902IVMerckPhase 2
52
SitagliptinMerckPhase 1
33
Low Dose Bisoprolol + High Dose BisoprololMerckApproved
85
rolofyline + Comparator Placebo (unspecified)MerckPhase 2
52
rolofylline + Comparator: Placebo (unspecified)MerckPhase 3
77
rolofylline + Comparator: Placebo (unspecified)MerckPhase 3
77
vildagliptin + placebo of vildagliptinNovartisApproved
85
Relaxin + PlaceboNovartisPhase 2/3
65
RelaxinNovartisPhase 2
52

Other Products from Nuwellis

Stepped pharmacologic carePhase 3
69
IV Loop Diuretics (LD)Pre-clinical
15
IV Loop DiureticsPre-clinical
15